{
  "title": "Secondary Malignancies",
  "category": "Radiation Oncology",
  "section": "Late Effects",
  "summary": "Radiation-induced secondary malignancies are a rare but serious late effect of radiation therapy, typically occurring 5-30 years after treatment with risk factors including age at exposure, dose, and genetic predisposition.",
  "content": [
    {
      "type": "heading",
      "level": 2,
      "text": "Epidemiology and Risk Factors"
    },
    {
      "type": "paragraph",
      "text": "The absolute risk of secondary malignancy is approximately 1 in 1000 patients per year of follow-up. Risk is highest in children and young adults, with solid tumors typically occurring 10-30 years post-treatment and hematologic malignancies within 5-10 years."
    },
    {
      "type": "heading",
      "level": 2,
      "text": "Common Secondary Malignancies"
    },
    {
      "type": "paragraph",
      "text": "Breast cancer (following chest irradiation for Hodgkin lymphoma), thyroid cancer (following neck irradiation), lung cancer (following chest irradiation), sarcomas (within radiation fields), and acute leukemia (dose-dependent, peaks at 5-9 years)."
    },
    {
      "type": "heading",
      "level": 2,
      "text": "Prevention and Monitoring"
    },
    {
      "type": "paragraph",
      "text": "Risk reduction strategies include minimizing radiation dose and volume, avoiding radiation in young patients when possible, and implementing long-term surveillance protocols based on radiation sites and patient age at treatment."
    },
    {
      "type": "clinical_pearl",
      "text": "The benefit-risk ratio strongly favors radiation therapy for most cancer patients, as the risk of secondary malignancy is far outweighed by the benefit of curing the primary cancer."
    }
  ]
}
